Mcdonough K - Search Results

1

Principles for assessing disease management outcomes.

Fitzner K, Sidorov J, Fetterolf D, Wennberg D, Eisenberg E, Cousins M, Hoffman J, Haughton J, Charlton W, Krause D, Woolf A, Mcdonough K, Todd W, Fox K, Plocher D, Juster I, Stiefel M, Villagra V, Duncan I; Quality and Research Committee, Disease Management Association of America. Fitzner K, et al. Among authors: mcdonough k. Dis Manag. 2004 Fall;7(3):191-201. doi: 10.1089/dis.2004.7.191. Dis Manag. 2004. PMID: 15669579 Review.

2

Disease management interventions to improve outcomes in congestive heart failure.

Roglieri JL, Futterman R, McDonough KL, Malya G, Karwath KR, Bowman D, Skelly J, Warburton SW Jr. Roglieri JL, et al. Among authors: mcdonough kl. Am J Manag Care. 1997 Dec;3(12):1831-9. Am J Manag Care. 1997. PMID: 10178473 Free article.

3

Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population.

Schultz JS, O'Donnell JC, McDonough KL, Sasane R, Meyer J. Schultz JS, et al. Am J Manag Care. 2005 May;11(5):306-12. Am J Manag Care. 2005. PMID: 15898219 Free article.

4

Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.

Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP. Harley CR, et al. Among authors: mcdonough k. Expert Opin Pharmacother. 2008 Apr;9(5):669-76. doi: 10.1517/14656566.9.5.669. Expert Opin Pharmacother. 2008. PMID: 18345946

5

Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting.

Bullano MF, Kamat S, Wertz DA, Borok GM, Gandhi SK, McDonough KL, Willey VJ. Bullano MF, et al. Among authors: mcdonough kl. Am J Health Syst Pharm. 2007 Feb 1;64(3):276-84. doi: 10.2146/060104. Am J Health Syst Pharm. 2007. PMID: 17244877

6

Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.

Bullano MF, Wertz DA, Yang GW, Kamat S, Borok GM, Gandhi S, McDonough KL, Willey VJ. Bullano MF, et al. Pharmacotherapy. 2006 Apr;26(4):469-78. doi: 10.1592/phco.26.4.469. Pharmacotherapy. 2006. PMID: 16553504

7

Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.

Huse DM, Song X, Ozminkowski RJ, Maguire J, Williams SA, Borok GM, McDonough K. Huse DM, et al. Among authors: mcdonough k. Clin Ther. 2006 Sep;28(9):1425-42. doi: 10.1016/j.clinthera.2006.09.019. Clin Ther. 2006. PMID: 17062315

8

A projection of the impact of lipid-lowering therapy on high-risk employee disability and medical costs.

Song X, Huse DM, Williams SA, Borok GM, McDonough K, Ozminkowski RJ. Song X, et al. Among authors: mcdonough k. J Occup Environ Med. 2006 Oct;48(10):1014-22. doi: 10.1097/01.jom.0000237773.26755.78. J Occup Environ Med. 2006. PMID: 17033501

9

The state of our health.

McDonough K. McDonough K. AHIP Cover. 2006 Sep-Oct;47(5):59-60, 63. AHIP Cover. 2006. PMID: 17007329 No abstract available.

10

Dyslipidemia treatment among patients with coronary artery disease in a managed care organization.

Lewis BE, McDonough K. Lewis BE, et al. Among authors: mcdonough k. Am J Health Syst Pharm. 2004 May 15;61(10):1032-8. doi: 10.1093/ajhp/61.10.1032. Am J Health Syst Pharm. 2004. PMID: 15160779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

284 results

Search Page